. Author manuscript; available in PMC: 2015 Nov 1.

Published in final edited form as: Respir Med. 2014 Nov;108(11):1688–1695. doi: 10.1016/j.rmed.2014.09.017

Table 1.

Baseline Characteristics of Study Participants

	PCP+ (n = 49)	PCP− (n = 70)	P
Age (mean + SD)	42.9 + 7.6 (n = 49)	45.0 + 8.8 (n = 65)	0.1665
CD4 (mean + SD) (median, (IQR))	39.7 + 60.9 16 (39) (n = 23)	131.3 + 139.9 90 (153) (n = 44)	0.0048
Male % (n)	69.4 (n = 49)	68.6 (n = 70)	0.9246
Using ART % (n)	8.2 (n = 49)	40.0 (n = 70)	<0.0001
Prior PCP % (n)	18.6 (n = 43)	23.8 (n = 63)	0.5232
Taking proph % (n)	11.1 (n = 45)	38.2 (n = 68)	0.0016
Oral candida % (n)	50.0 (n = 48)	54.4 (n = 68)	0.6393

In this table n represents in each cell the number of patients with data available for analysis.

Chi-square test used to assess differences in frequencies.

t-test used to assess differences in age and log(CD4). Natural log of CD4 was used for analysis because of skew in data, but results were also verified with the Wilcoxon Rank Sum Test on untransformed values.